2011 annual financial data
Alnylam Pharmaceuticals 2011 Operating cash flow margin
Direct answer
Operating cash flow margin was -105.21%.
Operating income was -54,818,000 USD and net income was -57,649,000 USD.
Operating cash flow was -87,068,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 82,757,000 USD
- Operating income
- -54,818,000 USD
- Net income
- -57,649,000 USD
- Operating cash flow
- -87,068,000 USD